Drugs and Privilege: Big Business, Congress and the EpiPen

July 24, 2024 | admin

(COMMON DREAMS) Michael Kinship, August 31, 2016 — Cash and carry has become nothing more than standard operating procedure in politics and government, and it’s wrecking the republic. The whole system is rotten to the core, corrupted by big business and special interests from the seventh son to the seventh son.

Or daughter, as we learned these past few days when the news introduced us to Heather Bresch, CEO of a drug company called Mylan and daughter of Democratic US Sen. Joe Manchin III, who’s also the former governor of West Virginia.

Mylan manufactures and sells EpiPen, the emergency delivery system for an allergy drug, epinephrine, that can make the difference between life and sudden death. The cost for a two-pack of the devices has soared nearly 550 percent to $608.61. That’s a price far beyond the means of most families with kids threatened by possibly fatal allergic reactions.

At the same time, Bresch has seen her own compensation increase a whopping 671 percent, from $2,453,456 in 2007 (the year that Mylan bought EpiPen) to $18,931,068 in 2015.

[Heather Bresch] should resign for price gouging rather than get a raise, but like so many of her fellow executives she sails serenely on as her fellow Americans drown in health care debt.

Source: Drugs and Privilege: Big Business, Congress and the EpiPen | Common Dreams | Breaking News & Views for the Progressive Community

Related Articles

Health, Legislation

MSCC Collected Letters Of Support For Chris Marte’s Health Care Bill 1096-2024

Read More
Health, Legislation

Bill 1096-2024: A Stab At Corporate And Governing Collusion

Read More
Health

I Was a Health Insurance Executive. What I Saw Made Me Quit

Read More

Make NYC a better place –
sign up for our newsletter!